MaxCyte, Inc. Shareholders' Equity
MaxCyte, Inc. (MXCT) had Shareholders' Equity of $158.75 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $158.75M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $167.89M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $171.49M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $180.28M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $158.75M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $167.89M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $171.49M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $180.28M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $190.72M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $199.41M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $206.25M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $213.30M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $221.26M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $226.36M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $232.17M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $233.38M 10-Q · filed 2024-11-06 | $233.38M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $240.98M 10-Q · filed 2024-11-06 | $240.98M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $247.82M 10-Q · filed 2024-11-06 | $247.82M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $253.97M 10-K · filed 2025-03-11 | $253.97M 10-K · filed 2023-03-15 |
| 2022-09-30 | $254.43M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $257.22M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $262.18M 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $262.90M 10-K · filed 2024-03-12 | $262.90M 10-K · filed 2022-03-22 |
| 2021-09-30 | $264.12M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $78.82M 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $81.29M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $33.23M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $34.99M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $37.21M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $11.09M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $13.60M 10-K · filed 2022-03-22 | |
| 2018-12-31 | $12.28M 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |